- Home
- JAZZ vs LNC Comparison
JAZZ vs LNC Comparison
Compare JAZZ & LNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- LNC
- Stock Information
- Founded
- JAZZ 2003
- LNC 1905
- Country
- JAZZ Ireland
- LNC United States
- Employees
- JAZZ N/A
- LNC N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- LNC Life Insurance
- Sector
- JAZZ Health Care
- LNC Finance
- Exchange
- JAZZ Nasdaq
- LNC Nasdaq
- Market Cap
- JAZZ 6.5B
- LNC 5.4B
- IPO Year
- JAZZ 2007
- LNC N/A
- Fundamental
- Price
- JAZZ $122.37
- LNC $35.07
- Analyst Decision
- JAZZ Buy
- LNC Hold
- Analyst Count
- JAZZ 14
- LNC 11
- Target Price
- JAZZ $173.57
- LNC $32.73
- AVG Volume (30 Days)
- JAZZ 613.8K
- LNC 1.6M
- Earning Date
- JAZZ 11-06-2024
- LNC 10-31-2024
- Dividend Yield
- JAZZ N/A
- LNC 5.13%
- EPS Growth
- JAZZ 458.10
- LNC N/A
- EPS
- JAZZ 7.04
- LNC 1.54
- Revenue
- JAZZ $3,992,712,000.00
- LNC $13,545,000,000.00
- Revenue This Year
- JAZZ $7.43
- LNC N/A
- Revenue Next Year
- JAZZ $6.39
- LNC $4.20
- P/E Ratio
- JAZZ $17.64
- LNC $22.77
- Revenue Growth
- JAZZ 5.23
- LNC N/A
- 52 Week Low
- JAZZ $99.06
- LNC $23.14
- 52 Week High
- JAZZ $134.17
- LNC $36.98
- Technical
- Relative Strength Index (RSI)
- JAZZ 59.35
- LNC 57.78
- Support Level
- JAZZ $108.74
- LNC $34.82
- Resistance Level
- JAZZ $128.99
- LNC $36.39
- Average True Range (ATR)
- JAZZ 2.93
- LNC 1.12
- MACD
- JAZZ 1.13
- LNC 0.06
- Stochastic Oscillator
- JAZZ 62.86
- LNC 63.68
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About LNC Lincoln National Corporation
Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability and dental.